UK businesses can apply for up to £16 million to grow manufacturing capacity for UK viral vector use in advanced therapy medicinal products.
Programme: Innovate UK
Award: Up to £6m
Opens: 23rd Oct 2017
Closes: 15th Nov 2017
Projects need to demonstrate that the capital investment grant they’re requesting will:
Innovate UK will support organisations that can set out a clear vision of how they will encourage partnerships with companies, universities and other research establishments. You should also detail the new viral vector projects you will undertake as a result of the capital investment.
You must have a clear plan for the translation and commercialisation of any research that the capital enables you to conduct. To maximise the impact of this investment, applicants should build on existing UK infrastructure and not recreate capabilities without justification.
Examples of in-scope applications include, but are not limited to, bids that aim to:
To lead a project you must:
Funding and project details
This competition is for capital investment, including refurbishment and equipment. Funding cannot go towards salaries or consumables. Capital can include the cost of setting up equipment but not the costs of maintenance or staff.
Your project should focus on investment aid for research infrastructures. Support given for construction or upgrade of research infrastructures that perform economic activities is considered to be state aid and is limited to 50% of the investment costs.
Projects should range in size from total costs of £2 million to £6 million.
The maximum funding for eligible project costs is:
Priority will be given to proposals that: